SARS-CoV-2-IN-35_product_DataBase

CAS: 2757763-47-4 F: C29H34F3N5O5S W: 621.67

SARS-CoV-2-IN-35 is a potent and orally active SARS-CoV-2 M pro inhibitor with a Ki value of 12.1 nM. SARS-CoV-2-IN-35 c

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity	SARS-CoV-2-IN-35 is a potent and orally active SARS-CoV-2 M pro inhibitor with a Ki value of 12.1 nM. SARS-CoV-2-IN-35 can be used in research of COVID-19[1].
In Vivo	SARS-CoV-2-IN-35 (compound 5; 10 mg/kg; p.o.) has good oral utilization in Wistar-Han rats[1]. Animal Model:
Name	SARS-CoV-2-IN-35
CAS	2757763-47-4
Formula	C29H34F3N5O5S
Molar Mass	621.67
Transport	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Reference	[1]. Owen DR, et, al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science. 2021 Dec 24;374(6575):1586-1593.

PeptideDB